“INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING”. 2026. Frontier in Medical and Health Research 4 (5): 567-85. https://fmhr.net/index.php/fmhr/article/view/2904.